Trial Profile
Phase 1 Clinical Trial to Evaluate the Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis.
Status:
Not stated
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2021
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy-Kangstem Biotech (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors Kangstem Biotech
- 13 Mar 2018 Planned End Date changed from 1 Dec 2020 to 1 Dec 2021.
- 13 Mar 2018 Planned primary completion date changed from 1 Nov 2020 to 1 Dec 2021.
- 13 Mar 2018 Status changed from not yet recruiting to recruiting.